1 false false false false false false false false false false true false false false false true false 2022-06-01 Sage Accounts Production Advanced 2023 - FRS102_2023 1,785,190 1,785,190 1,785,190 xbrli:pure xbrli:shares iso4217:GBP 11999930 2022-06-01 2023-05-31 11999930 2023-05-31 11999930 2022-05-31 11999930 2021-06-01 2022-05-31 11999930 2022-05-31 11999930 2021-05-31 11999930 bus:Director1 2022-06-01 2023-05-31 11999930 bus:Director2 2022-06-01 2023-05-31 11999930 bus:CompanySecretary1 2022-06-01 2023-05-31 11999930 core:WithinOneYear 2023-05-31 11999930 core:WithinOneYear 2022-05-31 11999930 core:RetainedEarningsAccumulatedLosses 2021-06-01 2022-05-31 11999930 core:RetainedEarningsAccumulatedLosses 2022-06-01 2023-05-31 11999930 core:ShareCapital 2023-05-31 11999930 core:ShareCapital 2022-05-31 11999930 core:RetainedEarningsAccumulatedLosses 2023-05-31 11999930 core:RetainedEarningsAccumulatedLosses 2022-05-31 11999930 core:ShareCapital 2021-05-31 11999930 core:RetainedEarningsAccumulatedLosses 2021-05-31 11999930 core:LandBuildings core:OwnedOrFreeholdAssets 2023-05-31 11999930 core:LandBuildings core:OwnedOrFreeholdAssets 2022-05-31 11999930 bus:SmallEntities 2022-06-01 2023-05-31 11999930 bus:AuditExempt-NoAccountantsReport 2022-06-01 2023-05-31 11999930 bus:SmallCompaniesRegimeForAccounts 2022-06-01 2023-05-31 11999930 bus:PrivateLimitedCompanyLtd 2022-06-01 2023-05-31 11999930 bus:FullAccounts 2022-06-01 2023-05-31
COMPANY REGISTRATION NUMBER: 11999930
PLOT 6 SARM WEST RESIDENCES LTD
Unaudited Financial Statements
31 May 2023
PLOT 6 SARM WEST RESIDENCES LTD
Financial Statements
Year ended 31 May 2023
Contents
Page
Directors' report
1
Income statement
2
Statement of financial position
3
Statement of changes in equity
4
Notes to the financial statements
5
PLOT 6 SARM WEST RESIDENCES LTD
Directors' Report
Year ended 31 May 2023
The directors present their report and the unaudited financial statements of the company for the year ended 31 May 2023 .
Principal activities
The principal activity of the company during the year was managment of owned propery based in the UK.
Directors
The directors who served the company during the year were as follows:
Mrs Anthi Belle
Mr Aristeidis Belles
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 29 January 2024 and signed on behalf of the board by:
Mrs Anthi Belle
Mr Aristeidis Belles
Director
Director
Fiduci-Corp (UK) Services Limited
Company Secretary
PLOT 6 SARM WEST RESIDENCES LTD
Income Statement
Year ended 31 May 2023
2023
2022
Note
£
£
Administrative expenses
( 71,250)
( 71,038)
Other operating income
50,072
46,778
--------
--------
Operating loss
( 21,178)
( 24,260)
Interest payable and similar expenses
5
( 58)
--------
--------
Loss before taxation
( 21,178)
( 24,318)
Tax on loss
--------
--------
Loss for the financial year
( 21,178)
( 24,318)
--------
--------
All the activities of the company are from continuing operations.
The company has no other recognised items of income and expenses other than the results for the year as set out above.
PLOT 6 SARM WEST RESIDENCES LTD
Statement of Financial Position
31 May 2023
2023
2022
Note
£
£
Fixed assets
Tangible assets
6
1,785,190
1,785,190
Current assets
Debtors
7
15,822
38,958
Cash at bank and in hand
132,549
141,696
---------
---------
148,371
180,654
Creditors: amounts falling due within one year
8
12,783
23,888
---------
---------
Net current assets
135,588
156,766
------------
------------
Total assets less current liabilities
1,920,778
1,941,956
------------
------------
Net assets
1,920,778
1,941,956
------------
------------
Capital and reserves
Called up share capital
2,033,989
2,033,989
Profit and loss account
( 113,211)
( 92,033)
------------
------------
Shareholders funds
1,920,778
1,941,956
------------
------------
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the year ending 31 May 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 29 January 2024 , and are signed on behalf of the board by:
Mrs Anthi Belle
Mr Aristeidis Belles
Director
Director
Company registration number: 11999930
PLOT 6 SARM WEST RESIDENCES LTD
Statement of Changes in Equity
Year ended 31 May 2023
Called up share capital
Profit and loss account
Total
£
£
£
At 1 June 2021
2,033,989
( 67,715)
1,966,274
Loss for the year
( 24,318)
( 24,318)
------------
--------
------------
Total comprehensive income for the year
( 24,318)
( 24,318)
At 31 May 2022
2,033,989
( 92,033)
1,941,956
Loss for the year
( 21,178)
( 21,178)
------------
--------
------------
Total comprehensive income for the year
( 21,178)
( 21,178)
------------
---------
------------
At 31 May 2023
2,033,989
( 113,211)
1,920,778
------------
---------
------------
PLOT 6 SARM WEST RESIDENCES LTD
Notes to the Financial Statements
Year ended 31 May 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is St Georges House, 6th Floor, 15 Hanover Square, London, W1S 1HS, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2022: 1 ).
5. Interest payable and similar expenses
2023
2022
£
£
Other interest payable and similar charges
58
----
----
6. Tangible assets
Freehold property
£
Cost
At 1 June 2022 and 31 May 2023
1,785,190
------------
Depreciation
At 1 June 2022 and 31 May 2023
------------
Carrying amount
At 31 May 2023
1,785,190
------------
At 31 May 2022
1,785,190
------------
7. Debtors
2023
2022
£
£
Rent deposit
5,000
5,000
Other debtors
10,822
33,958
--------
--------
15,822
38,958
--------
--------
8. Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
654
960
Accruals and deferred income
3,055
1,500
Other creditors
4,074
16,428
Rent deposit
5,000
5,000
--------
--------
12,783
23,888
--------
--------